Investment and M&A transaction comps
Supplements Investment & M&A Transaction Comps
Reviewed transaction comps tagged supplements, including disclosed, estimated and rumored values where source notes or calculation basis are available.
12
Reviewed transactions
7
With price data
4.0x
Median EV or valuation / revenue
17.6x
Median EV or valuation / EBITDA
Sortable transaction comps
Supplements transaction table
Rows with reported value
7 / 12
Acquisition value, USD
USD 9.4B
Investment capital, USD
-
Median EV or valuation / revenue
4.0x
Select up to 12 rows across filters and pages, then share or export the set.
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
12 shown of 12 matching transactions. Click any transaction row for more detail.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thorne Control | 2026-08-04 | Procter & Gamble | USD 3.8B Consideration | 3,800 | - | - | United States | Estimated 1 source | ||
| Vitabiotics Control | 2026-07-24 | Bain Capital | Undisclosed Undisclosed | Undisclosed | - | - | United Kingdom | Confirmed 1 source | ||
| Grüns Control (80%) | 2026-04-09 | Unilever | EUR 767M Consideration | 896 | 4.0x | - | United States | Estimated 2 sources | ||
| Sunday Natural Control (55%) | 2024-01-15 | CVC Capital Partners | EUR 800M Enterprise Value | 875 | 8.0x | 16.0x | Germany | Estimated 1 source | ||
| Thorne HealthTech Control | 2023-08-28 | L Catterton | USD 681M Enterprise Value | 681 | 3.7x | 21.2x | - | Estimated 2 sources | ||
| Blackmores Control (100%) | 2023-04-26 | Kirin | USD 1.2B Enterprise Value | 1,241 | 2.9x | 23.1x | Australia | Estimated 3 sources | ||
| The Better Health Company Control | 2022-06-29 | Nestle | Undisclosed Undisclosed | Undisclosed | - | - | New Zealand | Estimated 2 sources | ||
| Smarty Pants Control | 2020-11-25 | Unilever | Undisclosed | Undisclosed | 4.0x | - | - | Confirmed 1 source | ||
| Care/of Control | 2020-08-31 | Bayer | USD 225M | 225 | - | - | United States | Confirmed 1 source | ||
| Vitaco Control | 2016-08-01 | Primavera Capital | Undisclosed | Undisclosed | 1.5x | 14.7x | Australia/New Zealand | Confirmed 1 source | ||
| Swisse Control (3%) | 2015-09-17 | Biostime | USD 1.7B Consideration | 1,670 | - | 15.5x | Australia | Confirmed 1 source | ||
| Schiff Nutrition Control | 2012-11-22 | Reckitt Benckiser | Undisclosed | Undisclosed | 4.2x | 19.1x | - | Confirmed 1 source |
FundComb transaction comps are informational only. Values may be estimated, rumored, incomplete or derived from public information and should not be relied upon as financial, investment or valuation advice.